Cargando…
Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease
Parkinson's disease (PD) is a widespread neurodegenerative disorder. Despite the intensive studies of this pathology, in general, the picture of the etiopathogenesis has still not been clarified fully. To understand better the mechanisms underlying the pathogenesis of PD, we analyzed the expres...
Autores principales: | Alieva, Anelya Kh., Filatova, Elena V., Karabanov, Aleksey V., Illarioshkin, Sergey N., Slominsky, Petr A., Shadrina, Maria I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592918/ https://www.ncbi.nlm.nih.gov/pubmed/26483988 http://dx.doi.org/10.1155/2015/294396 |
Ejemplares similares
-
Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2014) -
VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson’s disease
por: Alieva, Anelya, et al.
Publicado: (2020) -
Housekeeping Genes for Parkinson’s Disease in Humans and Mice
por: Alieva, Anelya Kh., et al.
Publicado: (2021) -
Expression Analysis of Genes Involved in Transport Processes in Mice with MPTP-Induced Model of Parkinson’s Disease
por: Rudenok, Margarita M., et al.
Publicado: (2022) -
Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson's Disease
por: Semenova, Ekaterina I., et al.
Publicado: (2023)